Financial statements Aesthetic Pharma

Balance sheet of Aesthetic Pharma

Company age:
Age:
9 y. 11 m. 4 d.
Share capital:
Share capital:
20 000 PLN

Balance sheet data of AESTHETIC PHARMA

Year
2018
2019
2020
2021
2022
Total assets 249 632,94 238 919,86 271 023,38 373 807,41 391 385,31
A. Fixed assets 0,00 0,00 0,00 0,00 0,00
B. Current assets 249 632,94 238 919,86 271 023,38 373 807,41 391 385,31
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 249 632,94 238 919,86 271 023,38 373 807,41 391 385,31
A. Equity 32 583,96 37 845,37 50 552,33 124 893,34 128 587,56
B. Liabilities and provisions for liabilities 217 048,98 201 074,49 220 471,05 248 914,07 262 797,75
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 217 048,98 201 074,49 220 471,05 248 914,07 262 797,75
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.